Type 2 Diabetes Archives - Page 2 of 2 - BCDiabetes

What Is Good For Athletes Is Good For People With Diabetes

Research

A recent article shows that superior performance can be achieved by professional cyclists using ketones as preferred fuel rather than traditional carbohydrate or fat. This information comes hard on the heels of exciting new evidence for the benefits of the sglt2 inhibitor class of drugs in Type 2 diabetes. It may well be that they these […]

READ MORE

Role of Self-Compassion in Diabetes Control

Living With Diabetes, Research

A recent randomized control trial involving a mindful, self-compassion (MSC) intervention showed that that the intervention “increased self-compassion and produced statistically and clinically significant reductions in depression and diabetes distress in the intervention group, with results maintained at 3-month follow-up.” In addition, MSC participants showed a decrease in A1c versus the control group. At BCDiabetes we […]

READ MORE

Important Type 2 Diabetes Results Reported

Living With Diabetes, Research

Today the results of 2 important studies in Type 2 diabetes presented at the annual American Diabetes Association meeting in New Orleans this week were published in the prestigious New England Journal of Medicine. The LEADER study examined the outcomes of 9,340 patients with Type 2 diabetes followed for four years. All took standard diabetes […]

READ MORE

Third SGLT2 inhibitor to be marketed in Canada

Research

Empagliflozin “Jardiance” is the third member of the SGLT2 inhibitor class to be marketed in Canada.  Like the other two members of the class (canagliflozin “Invokana” and dapagliflozin “Forxiga”) it lowers blood sugar and weight by causing wasting of sugar/glucose in the urine.  This results in increased urine volumes in all patients and a tripling […]

READ MORE

New Study To Test Whether GLP-1 Agents Help You or Hurt You Before Taking The Drug

Announcements, Research

We are very excited about this made-in-BC research to help us find out if a drug will be beneficial for those taking it or whether it might make them ill before ever taking the drug. From Dr. Tom Elliott: “A new class of medication for diabetes known as GLP-1 agents have been on the Canadian market […]

READ MORE

Canadian Diabetes Association Proposes a Tax on Sugary Drinks

Food & Nutrition

This federal election, the Canadian Diabetes Association (CDA) is recommending a tax on sugar-sweetened beverages (SSBs) to fight type 2 diabetes and improve the health of Canadians. – See the CDA recommendation here. There is a strong association between the consumption of SSBs and the development of Type 2 diabetes: for every regular-sized can of sugar-sweetened […]

READ MORE

U.S. FDA warns on SGLT2 inhibitors, a class of type 2 diabetes drugs

Announcements, Research

This past Friday the US Federal Drug Administration released a warning that some newer type 2 diabetes drugs, known as SGLT2 inhibitors, may cause ketoacidosis, or dangerously high levels of blood acids that could require hospitalization. The warning comes from the US, but what does this mean for Canada. Our Medical Director, Dr. Tom Elliott, lets us know. […]

READ MORE

Guest Post: Diabetes and Your Feet

Living With Diabetes

Dr. Jaspaul Riar The Canadian Diabetes Association projects that by 2020, one in three Canadians will have diabetes, be pre-diabetic or have undiagnosed diabetes. These numbers are startling, but what is more shocking is the number of foot amputations this is causing. In 2011-2012, Canadians suffered 2000 foot amputations due to diabetic wounds. This is […]

READ MORE

Dieting – Which diet is right for you?

Food & Nutrition, Research

Earlier this month, Kathryn Doyle wrote a piece for Reuters Health on diets with the headline: “Diets work, but the brand doesn’t matter.” One need not travel far into the media sphere to hear about diets – there are commercials, gurus, ‘experts’, actual experts, various programs with a wide assortment of menus from all-fat to no-fat and […]

READ MORE
Translate »